A Revolution in Medicine and Surgery Has Begun - 12/03/25
Abstract |
In the last few years, the longevity of Americans has fallen for the first time in our history. Obesity has mushroomed, heart disease still kills approximately 600,000 Americans, and stroke 150,000. This review will cover the 8 most important nongenetic risk factors for heart disease and stroke. Meanwhile, recent research has clarified the root cause of atherosclerosis. The approval of tirzepatide to treat obesity in November 2023 by the FDA turns out to have enormous implications for medicine and surgery and the food industry.
Le texte complet de cet article est disponible en PDF.Keywords : Revolution, Tirzepatide to Treat Obesity, Trimethylamine oxide (TMAO) as cause of atherosclerosis
| Funding: No funding associated with this article. |
|
| Conflict of Interest: No conflict of interest. |
|
| Authorship: Solely responsible for all content and conceptualization. RS: Conceptualization, Formal analysis, Writing – original draft. |
Bienvenue sur EM-consulte, la référence des professionnels de santé.
L’accès au texte intégral de cet article nécessite un abonnement.
Déjà abonné à cette revue ?